Navigation Links
Oncolytics Biotech Inc. Announces Publication of Research on Combination Reovirus and Radiation Therapy
Date:2/3/2008

CALGARY, Feb. 4 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) ('Oncolytics') reported today that Dr. Kevin Harrington and his research group at The Institute of Cancer Research, London, U.K. published the results of their work testing combination treatment schedules of reovirus and radiation in human and murine tumour cells in vitro and in vivo. The paper, entitled "Enhanced In vitro and In vivo Cytotoxicity of Combined Reovirus and Radiotherapy" appears online in the February 1, 2008 issue of Clinical Cancer Research.

The effect of different schedules of reovirus and radiotherapy on viral replication and cytotoxicity was tested in vitro and the combination was assessed in three tumour models in vivo. The results demonstrated that combining reovirus and radiotherapy significantly increased cancer cell killing both in vitro and in vivo, particularly in cell lines with moderate susceptibility to reovirus alone.

"Dr. Harrington's work demonstrates convincingly that REOLYSIN(R) works to enhance the effects of radiation therapy," said Dr. Matt Coffey, Chief Scientific Officer of Oncolytics. "The results of this preclinical research provided strong support for the combination REOLYSIN(R) and radiation clinical trials we are conducting in the U.K. To date, we have successfully completed enrolment in a Phase Ia/Ib combination REOLYSIN(R) and radiation trial and are currently enrolling patients in a Phase II trial using this combination."

About Oncolytics Biotech Inc.

Oncolytics is a Calgary-based biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics. Oncolytics' clinical program includes a variety of Phase I and Phase II human trials using REOLYSIN(R), its proprietary formulation of the human reovirus, alone and in combination with radiation or chemotherapy. For further information about Oncolytics, please visit

SOURCE Oncolytics Biotech Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Oncolytics Biotech Inc. Announces Issuance of 23rd U.S. Patent
2. Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
3. Media Advisory - Oncolytics Biotech Inc. to Present at BioPartnering Europe
4. Media Advisory - Oncolytics Biotech Inc. to Present at BIO InvestorForum 2007
5. Oncolytics Biotech Inc. Announces Approval for U.K. Clinical Trial Investigating REOLYSIN(R) in Combination with Cyclophosphamide
6. Oncolytics Biotech Inc. Collaborators to Present Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
7. Oncolytics Biotech Inc. Announces 2007 Third Quarter Results
8. Media Advisory - Oncolytics Biotech Inc. to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
9. Media Advisory - Oncolytics Biotech Inc. to Present at Toronto CFA Society
10. Oncolytics Biotech Inc. Announces Issuance of 24th U.S. Patent
11. Oncolytics Biotech Inc. to Present at Annual Vaccine Production Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2008)...OUIS, Sept. 4 /- SAFC Hitec...e Sigma-Aldrich Group (Nasdaq: SIAL ),today anno...eloping,Germanium Antimony Telluride (Ge(x)Sb(y)Te...facturing phase change memory (PCM) applications. ... both the precursors and with the,use of conventio...
(Date:9/3/2008)...oned Industry Executive to Lead Company,s Business...ves, BEDFORD, Mass., Sept. 3 /PRNewswire-FirstCal...ader in patch pump technology with its OmniPod(R),...ointment of William,"Bill" D. Arthur III as Vice P.... Arthur will lead the company,s business developm...
(Date:9/3/2008)... Cearnal appointed Senior Vice President, Commerci...wire/ -- Cumberland Pharmaceuticals,Inc. has appoi...Vice,President, Commercial Development. In this ne...involved with Cumberland,s commercial strategy and...://www.newscom.com/cgi-bin/prnh/20080903/CLW115 )...
(Date:9/3/2008)...O CORDOVA, Calif., Sept. 3 /PRNewswire-FirstCall/ ... supplier of innovative products that,process and ...port,financial results for the fourth quarter and ...er 9, 2008., Company,s Conference Call and Webcas..., September 9, 2008 at,2:00 PM Pacific (5:00 PM Ea...
Breaking Biology Technology:SAFC Hitech(TM) Successfully Demonstrates Device-Quality GST Precursors For Phase Change Memory Applications 2SAFC Hitech(TM) Successfully Demonstrates Device-Quality GST Precursors For Phase Change Memory Applications 3SAFC Hitech(TM) Successfully Demonstrates Device-Quality GST Precursors For Phase Change Memory Applications 4Insulet Appoints Bill Arthur as Vice President of Business Development 2Insulet Appoints Bill Arthur as Vice President of Business Development 3Insulet Appoints Bill Arthur as Vice President of Business Development 4Cumberland Pharmaceuticals Taps Industry Veteran for Key Executive Position 2ThermoGenesis Corp. to Announce Fourth Quarter and Year End Results for Fiscal 2008 on September 9, 2008 2
...Childrens Hospital of Wisconsin is helping to hea...en by freezing the tissue causing the abnormality....oCath Technologies reaches temperatures as low as.... In the catheterization laboratory at Childrens H...iologist guide the catheter through a vein into th...
...onsin has long offered specialized tax credits to ...lacked credit programs aimed at leveraging seed ca...s about to change. Act 255, a tax-credit package t... being refined through an administrative rule proc...new direction when it takes effect in 2005. , ,Lis...
...nager of integrated logistics, is implementing a s...s from RedPrairie , a Waukesha-based provider of ...apply numerous applications from RedPrairie,s Digi...ns, including RedPrairie,s entire transportation s...perational control and efficiency, and transition ...
...s is one way businesses can create organic growth ...ry expert in new product development (NPD) is Rub... , ,New products can be sold into existing markets...pment and launch is a new product into a new marke...arket (because your clients already know and love ...
Other Biology Technology:State investment incentives aimed at luring angels to start-up companies 2Seven reasons new technology product development goes astray 2Seven reasons new technology product development goes astray 3Seven reasons new technology product development goes astray 4
(Date:9/4/2008)...e University and the Serum Institute of India coul...r children living in some of the most impoverished...ed $250,000 to a team of SU researchers led by Rob... College of Arts and Sciences, to develop new oral...form of diarrhea that affects infants and young ch...
(Date:9/4/2008)...s are constantly evolving in ways that increase th...tuations and internal errors. Now, in a study of c... team has found new evidence that evolution has pr...uited to handle potentially harmful changes like g...blished online this week in the journal PNAS , co...
(Date:9/4/2008)...e the tuna population? Can we compute how to trans...oduction? , Those and other questions will be ta...ns, economists, biologists and environmental scien...titute for Computational Sustainability, being lau...cience Foundation (NSF). This program is designed ...
(Date:9/4/2008)...y company have joined forces to develop a world-fi... predict premature birth with greater accuracy., ...castle and Symbion Pathology are combining,expert... to develop a computer program to predict,women a...rm births occur in Australia each year. Premature ...
Breaking Biology News(10 mins):Syracuse University partners with Serum Institute of India to develop vaccines for children 2Syracuse University partners with Serum Institute of India to develop vaccines for children 3Syracuse University partners with Serum Institute of India to develop vaccines for children 4New evidence on the robustness of metabolic networks 2Cornell gets $10 million NSF grant to establish new sustainability institute 2World-first to predict premature births 2Genetic Mutations Boost Prostate Cancer Risk 9657 1Genetic Mutations Boost Prostate Cancer Risk 9657 2Genetic Mutations Boost Prostate Cancer Risk 9657 32 federal public health grants awarded to Weill Cornell Medical College 1930 12 federal public health grants awarded to Weill Cornell Medical College 1930 2UNC Duke lead first statewide shaken baby prevention research project in US 9654 1UNC Duke lead first statewide shaken baby prevention research project in US 9654 2UNC Duke lead first statewide shaken baby prevention research project in US 9654 3UNC Duke lead first statewide shaken baby prevention research project in US 9654 4GM Coskata partnership builds on Oklahoma State University biofuels research 1928 1GM Coskata partnership builds on Oklahoma State University biofuels research 1928 2GM Coskata partnership builds on Oklahoma State University biofuels research 1928 3
...arry hepatitis E virus (HEV), which they can pass ...d in Online Open Access journal BMC Veterinary Res...ise the risk of human infection. The scenario huma...n rate in pigs drops. At low infection rates, ther...V to humans at slaughter. , Kunio Satou and Hirosh...
...he advent of more powerful and economical DNA sequ...zation is transitioning from single-organism studi...ations embedded in communities of microbial genome...till in its infancy -- the equivalent of the early... to stake their claim. , Amidst the prospecting,...
...beings are directly responsible for more than 110,...since the Industrial Revolution. Every year, we "i...m contaminants, which are emitted into the environ...ir, soil and water. Nonetheless, human beings are ... (what is known in this scientific field as "inadv...
...chers observing wild chimpanzees in Uganda have di...orly understood behavior: female-led infanticide. ...ocombe and colleagues of the University of St. And...anda, appear in the May 15th issue of the journal ...icide is known to occur in many primate species, b...
Other Biology News:DOE JGI sets 'gold standard' for metagenomic data analysis 2DOE JGI sets 'gold standard' for metagenomic data analysis 3DOE JGI sets 'gold standard' for metagenomic data analysis 4100 percent of pregnant women have at least one kind of pesticide in their placenta 2100 percent of pregnant women have at least one kind of pesticide in their placenta 3Female-led infanticide in wild chimpanzees 2
A high quality source of amino acids and peptides produced by the enzymatic digestion of casein. It is recommended for laboratory media and fermentations and has been used in antibiotics, toxins and
QIAshredder (50) from QIAGEN
...n Ham's F12K medium with 2 mM L-glutamine and harv... the antigens in their native forms, cells were fi...a 12-well (5 mm) adhesive coated slide, with each ...ular attachment and to minimize background stainin...
Mouse polyclonal antibody to REXO4 - XPMC2 prevents mitotic catastrophe 2 homolog (Xenopus laevis)
Biology Products: